Clinical Trial Update: Hemlibra in Mild Hemophilia A [Phase 4]

View source ↗

Summary

Phase 4 trial update exploring Hemlibra (emicizumab) for patients with mild Factor VIII deficiency (congenital) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Factor Viii Deficiency Congenital

Drugs mentioned

• Hemlibra (emicizumab)

Snippet

Sponsor: Indiana Hemophilia &Thrombosis Center, Inc. | Conditions: Factor VIII Deficiency, Congenital | Phase 4 | Status: RECRUITING